Most long term investors would say no way at $2.70, we were at $2.50 this time last year ... opportunistic bid ...I say no
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025